A comparison between MALDI-MS and CE-MS data for biomarker assessment in chronic kidney diseases

Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes

2007 • 1,452 citations

Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst

2011 • 1,096 citations

All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan

2008 • 894 citations

Progression, remission, regression of chronic renal diseases

2001 • 552 citations

Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease

2010 • 485 citations

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

2008 • 425 citations

Prestructured MALDI-MS Sample Supports

2000 • 324 citations

Recommendations for Biomarker Identification and Qualification in Clinical Proteomics

2010 • 306 citations

Advances in Urinary Proteome Analysis and Biomarker Discovery

2007 • 276 citations

Urinary Proteomics in Diabetes and CKD

2008 • 273 citations

Quantitative Urinary Proteome Analysis for Biomarker Evaluation in Chronic Kidney Disease

2008 • 248 citations

Receiver operating characteristic laboratory (ROCLAB): Software for developing decision strategies that account for uncertainty

2002 • 215 citations

Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes

2004 • 209 citations

Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface‐enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry

2003 • 203 citations

Biological applications of support vector machines

2004 • 195 citations

Capillary electrophoresis–mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: An update of recent developments

2008 • 188 citations

SpecAlign--processing and alignment of mass spectra datasets

2005 • 172 citations

Urinary Peptidome May Predict Renal Function Decline in Type 1 Diabetes and Microalbuminuria

2009 • 144 citations

Multicentric Validation of Proteomic Biomarkers in Urine Specific for Diabetic Nephropathy

2010 • 131 citations

Addressing the Challenge of Defining Valid Proteomic Biomarkers and Classifiers

2010 • 114 citations

Identification and Validation of Urinary Biomarkers for Differential Diagnosis and Evaluation of Therapeutic Intervention in Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis

2009 • 111 citations

Evaluation of Urinary Biomarkers for Coronary Artery Disease, Diabetes, and Diabetic Kidney Disease

2009 • 105 citations

CE‐MS in biomarker discovery, validation, and clinical application

2010 • 103 citations

Capillary electrophoresis coupled to mass spectrometer for automated and robust polypeptide determination in body fluids for clinical use

2004 • 92 citations

Bio-support vector machines for computational proteomics

2004 • 87 citations

Combined Top-Down and Bottom-Up Mass Spectrometric Approach to Characterization of Biomarkers for Renal Disease

2005 • 86 citations

The urinary proteome in diabetes and diabetes‐associated complications: New ways to assess disease progression and evaluate therapy

2008 • 73 citations

Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic‐nephropathic patients: a MALDI study

2009 • 51 citations

Analysis of complex, multidimensional datasets

2006 • 43 citations

A further investigation on a MALDI‐based method for evaluation of markers of renal damage

2009 • 21 citations

Chip with Twin Anchors for Reduced Ion Suppression and Improved Mass Accuracy in MALDI-TOF Mass Spectrometry

2005 • 21 citations

Cited By (0)

Loading...